The 25 best cities for biotech jobs.

The three deepest clusters.

The top three are all in the United States, and together they hold more biotech roles, funding, and firms than the rest of the list combined. Each pairs a research university anchor with a venture funding base and a hospital system that supplies the clinical pipeline.

Four models of a hub.

Biotech does not spread evenly; it clusters near a research university, a teaching hospital, and a pool of patient venture capital. Four regional models produce the 25 cities above.

The United States super cluster model is the strongest. Boston, San Francisco, and San Diego each pair a top five research university with a teaching hospital network and the deepest biotech venture funding base in the world. The result is a self reinforcing loop: the science spins out companies, the companies attract funding, the funding draws talent, and the talent feeds the next spin out. Philadelphia runs a fast growing variant built on cell and gene therapy, the field its researchers pioneered, and Raleigh anchors the Research Triangle Park, the largest research park in the country. The tech jobs ranking tracks the overlap with the wider technology economy, and the highest paying cities ranking carries the salary read.

The European pharma anchor model runs on the back of established drug giants rather than venture spin outs. Basel is the headquarters of both Roche and Novartis, which gives a city of 175,000 people the highest biotech salary in Europe and a cluster that punches far above its size. Copenhagen anchors Medicon Valley near Novo Nordisk, the maker of the weight loss drugs that reshaped the industry. Zurich, Munich, and Paris run the same pattern of a large anchor firm plus a university base, at a lower salary but a lower cost than the United States. The Europe page sets the wider context.

The British Golden Triangle is a distinct European model worth separating. London, Cambridge, and Oxford form a triangle of research universities and the firms that spin out of them, anchored by AstraZeneca in Cambridge and the deepest academic medical research base outside the United States. The salaries trail the American clusters by a wide margin, which is the structural weakness of the British sector, but the science is world leading and the cost outside London runs below the United States hubs. The United Kingdom page carries the read.

The Asian growth model is the fastest moving. Shanghai holds 60,000 roles in the Zhangjiang Hi Tech Park and has gone from a contract manufacturing base to an origin of novel drugs in a decade. Singapore built its Biopolis cluster through deliberate state investment, and Tokyo runs an established pharma sector. The Indian hubs of Bangalore and Hyderabad, the latter home to Genome Valley, pair low salaries with the largest growth rates on the list and a deep base in generics and biosimilars. The Asia page tracks the region.

The cost overlay is what separates the clusters that retain talent from those that lose it. The leading United States hubs pay the most but absorb much of the premium in rent: a 135,000 dollar Boston salary against a 2,900 dollar central rent leaves a different surplus than a 98,000 dollar Raleigh salary against a 1,400 dollar rent. This is the structural reason the Research Triangle and the cell therapy cluster in Philadelphia have grown faster than the coastal super clusters over the 2022 to 2026 window, as mid career scientists trade optionality for a livable cost.

The funding cycle is the other variable that moves the rankings year to year. Biotech is the most capital intensive corner of the knowledge economy, and the clusters with the deepest venture base ride out the funding winters that periodically hit the sector. Boston and San Francisco hold the largest reserves of patient capital, which is why they recover fastest from each downturn; the emerging hubs feel the cycle more sharply. The highest paying cities ranking tracks how the funding cycle feeds through to salaries.

A note on the specialization that defines each hub. The leading clusters are not interchangeable; each leans toward a scientific niche shaped by its founding firms and universities. San Diego leads genomics and diagnostics on the back of Illumina; Philadelphia leads cell and gene therapy; Copenhagen leads metabolic disease through Novo Nordisk; Hyderabad leads vaccine manufacturing. A scientist should match the cluster to the subfield as much as to the salary, because the deepest career capital accrues where the relevant science concentrates.

The rest of the top 25.

A short read on the clusters that fill out the ranking, from the Swiss pharma giants to the fast rising Asian hubs.

Basel ranks fourth and first in Europe on the strength of two of the largest pharma firms in the world, Roche and Novartis, both headquartered in the same Rhine city. The 40,000 roles pay a median of 130,000 dollars, the highest in Europe, and the trinational location at the Swiss, French, and German border deepens the talent pool. The cost matches the salary; Swiss living expenses are the highest on the list.

London anchors the British Golden Triangle on 55,000 roles and the deepest academic medical base outside the United States, spanning the Francis Crick Institute, the universities, and the teaching hospitals. The salary trails the American hubs at a median of 85,000 dollars, and the London cost is the highest in Europe, which is the squeeze on the sector.

Cambridge holds the densest biotech base in Britain relative to its size, anchored by AstraZeneca and a research university that has produced a long line of life science spin outs. The 25,000 roles sit in a small city, which keeps the cluster tight but the housing tight too.

Copenhagen anchors Medicon Valley, the Danish and southern Swedish cluster, on the back of Novo Nordisk, whose weight loss drugs made it the most valuable company in Europe. The 42,000 roles pay a median of 95,000 dollars, and the Danish quality of life is among the highest on the list.

New York runs a 50,000 role cluster anchored by its academic medical centers and a growing base on the East Side life science corridor. The salary is high at 115,000 dollars, but the cost is the highest in the United States, and the cluster is less specialized than Boston or San Diego.

Philadelphia built the global center of cell and gene therapy, the field its researchers at Penn pioneered with the first approved CAR T treatments. The 48,000 roles and the Cellicon Valley nickname reflect a cluster punching above its cost, which runs well below the coastal hubs.

Zurich pairs a high salary at 125,000 dollars with the ETH research university and a base of mid sized firms. The 30,000 roles sit alongside a strong finance and tech sector, and the Swiss cost is the trade.

Raleigh anchors the Research Triangle Park, the largest research park in the United States, spanning 45,000 biotech roles across a low cost metro. The salary at 98,000 dollars buys far more house than the coastal hubs, which is the structural draw for mid career scientists.

Singapore built its Biopolis cluster through state investment, drawing the regional headquarters of global pharma firms. The 25,000 roles pay a median of 90,000 dollars, and the city pairs the science with the strongest business environment in Asia.

Munich runs the largest German biotech cluster, anchored by the universities and a base of firms including BioNTech research operations. The 28,000 roles pay a median of 90,000 dollars, and the cluster sits alongside the strongest corporate economy in Germany.

Paris anchors the French sector through the Genopole campus and the Institut Pasteur, with 35,000 roles. The salary trails at 75,000 dollars, a function of the French market, but the research base is deep and the public funding strong.

Tokyo runs an established pharma sector anchored by the large Japanese drug firms, with 40,000 roles. The salary at 80,000 dollars reflects the Japanese market, and the cluster leans toward established firms over venture spin outs.

Shanghai is the fastest growing cluster on the list, with 60,000 roles in the Zhangjiang district and a transition from contract work to novel drug origination over the past decade. The salary at 55,000 dollars is rising fast, and the growth rate leads the world.

Toronto anchors the Canadian sector on the back of the University of Toronto and a teaching hospital network, with 30,000 roles. The salary at 85,000 dollars and the immigration friendly policy draw international talent.

Stockholm anchors the Swedish sector surrounding the Hagastaden district and the Karolinska Institute, the body that awards the Nobel Prize in medicine. The 22,000 roles pay a median of 85,000 dollars, and the cluster pairs the research base with the highest quality of life in the Nordic region.

Oxford completes the British Golden Triangle on the back of its research university and a base of spin out firms, with 18,000 roles. The cluster is small but the science is among the best in the world, and the city pairs it with a lower cost than London.

Berlin runs a growing German biotech base anchored by the Charite hospital ecosystem and a deep talent pool, with 25,000 roles. The salary at 80,000 dollars sits below Munich, but the cost is lower and the startup culture deeper. The United States comparisons show the salary gap with the leading clusters.

Amsterdam anchors the Dutch sector on the back of the academic medical centers and a base of mid sized firms, with 20,000 roles. The salary at 80,000 dollars and the English friendly workplace draw international talent to the Netherlands.

Montreal runs the second Canadian cluster after Toronto, anchored by McGill University and a strong public funding base, with 22,000 roles. The salary at 75,000 dollars and the low cost relative to the United States make it a value entry, and the bilingual workforce is a feature for global firms.

Melbourne anchors the Australian sector surrounding the Parkville biomedical precinct, one of the densest research clusters in the Southern Hemisphere, with 24,000 roles. The salary at 80,000 dollars pairs with a high quality of life and a strong public research base.

Bangalore holds the largest Indian biotech base, anchored by Biocon, the country biggest biopharma firm, with 35,000 roles. The salary at 25,000 dollars is low in dollar terms but high in local buying power, and the growth rate and the deep generics base make it a rising hub.

Hyderabad rounds out the list on the strength of Genome Valley, a purpose built life science cluster, and a deep base in vaccines and generics, with 30,000 roles. The salary at 24,000 dollars buys a strong local lifestyle, and the city is a global center of vaccine manufacturing.

The same list, reordered by stage.

The right cluster depends on career stage, salary priority, and whether the household can absorb the cost of the leading hubs.

For the early career scientist, the play is the deepest cluster regardless of cost, because the optionality compounds. Boston and San Francisco let a researcher change employer without changing city, which de risks a biotech career where startups fail often. The high rent is the price of that optionality, and a shared apartment absorbs it. The Boston vs New York comparison and the cost of living calculator size the trade.

For the mid career scientist with a family, the calculation shifts toward the clusters that pair a deep job market with a livable cost. Raleigh, Philadelphia, and San Diego deliver a strong biotech base at a fraction of the Bay Area housing cost, and Copenhagen pairs the science with the highest family quality of life on the list. The families ranking carries the school and safety read.

For the senior scientist or executive chasing the top salary, the Swiss and American coastal hubs lead. Basel, Zurich, and the Bay Area pay the highest medians, and the senior roles at the anchor firms cluster there. The highest paying cities ranking and the tax calculator run the after tax math, which matters most at the senior salary band.

For the international scientist who needs a visa, the immigration policy is the gate. Toronto, Singapore, and London run the most accessible skilled worker routes, while the United States H1B lottery is the binding constraint on the deepest clusters. The 2026 visa guide covers each pathway, Wise handles the salary transfer, and SafetyWing covers the health gap on arrival. The expats ranking folds the visa access into the score.

For the academic making the jump from the lab bench to industry, the choice is the cluster with the shortest distance between the university and the firm. Boston and Cambridge in Britain run the tightest academic to industry pipelines on the list, where a postdoc can walk from a university lab to a startup founded by a former supervisor. Copenhagen, Stockholm, and Zurich run the same tight loop at a European scale. The transition is where most biotech careers are made, and the density of the cluster is what makes it possible.

For the reader weighing a move against staying put, the honest answer is that biotech rewards concentration more than almost any other field, so the cost of being in a thin market is real. A scientist in a single firm town carries the risk that the firm restructures; a scientist in San Diego or Basel can move down the street. The relocation score tool weighs the optionality against the cost and the lifestyle, and the relocation checklist covers the practical side of acting on the result.